![](/fileadmin/_processed_/csm_Amphistar_c6faa8b918.jpg)
AmphiStar BV secures €6m to expand production
The infusion of €6m in new capital from ECBF, Qbic III and FFTF will empower AmphiStar to kickstart commercial biosurfactant production in...
![](/fileadmin/_processed_/csm_NOVo_New_434e85ba4f.png)
Obesity: reseachers switch on brown fat cells
The new discovery could herald a revolution in obesity research. If the principle discovered in male mice also applies in humans, therapeutics...
![](/fileadmin/Content/NewsAndStories/2024/Rentschler_Biopharma_new_line_PR_SM.png)
Rentschler doubles cGMP capacity
According to a company spokesperson, the expansion in the main market for biopharmaceuticals doubles Rentschler's cGMP-compliant production capacity...
![](/fileadmin/_processed_/csm_Peter_Sondermann__c__Tacalyx_d5b3b6d2e0.jpg)
Tacalyx' extends seed capital financing
Tacalyx GmbH, the 2019 spin-out from Peter Seeberger's glycan research group, has doubled its seed funding from €7m to to a bit over €14m to advance...
![](/fileadmin/Content/NewsAndStories/2024/Bildschirmfoto_2024-07-09_um_09.31.12.png)
EMA-Gate: PharmaMar wins suit against EMA
The European Commission has corrected its decision C(2018) 4831 from 2018 not to grant marketing authorisation for Aplidin (plitidepsin), a peptidic...
![](/fileadmin/_processed_/csm_BMS_Evotec_072382e6ec.png)
Evotec SE cashes in €20m milestone
The partnership initiated in 2016 uses Evotec’s iPSC platform to create predictive patient-derived cell-based disease models that mimic the pathology...
![](/fileadmin/_processed_/csm_RNF31_Pub_domain__c__RCBS_protein_data_base_62ddf70879.jpg)
Flindr Therapeutics BV secures €20m Series A financing
The Series A financing was led by V-Bio Ventures and an international syndicate that includes Johnson & Johnson Innovation – JJDC, Inc., QBIC...